Haemonetics logo
HAEHaemonetics
Trade HAE now
Haemonetics primary media

About Haemonetics

Haemonetics (NYSE:HAE) specializes in the development and manufacturing of blood and plasma supplies and equipment. This focus encompasses a broad range of products and services designed to support blood processing, storage, and transfusion across various healthcare settings. Haemonetics aims to innovate within the blood management industry, striving to improve safety and efficiency in blood and plasma collection, processing, and analysis. Their projects and objectives revolve around enhancing patient care and supporting healthcare providers with advanced solutions for blood management, underscoring their commitment to saving lives and improving patient outcomes.

What is HAE known for?

Snapshot

Public US
Ownership
1971
Year founded
2208
Employees
Boston, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Boston, US

Produtos e/ou serviços de Haemonetics

  • Plasma Collection Systems and Software - Advanced equipment and software solutions designed to optimize the efficiency and safety of collecting plasma.
  • Blood Center Technologies - Comprehensive portfolio of devices, disposables, and software for blood and component collection.
  • Hospital Products - A range of devices and systems to manage blood and bleeding in surgical and emergency settings.
  • Cell Saver Systems - Leading technology for autologous blood recovery during surgical procedures, reducing the need for transfusions.
  • TEG Hemostasis Analyzer Systems - Diagnostic instruments and consumables that help assess and manage hemostasis in surgery and critical care.
  • NexSys PCS Device - Next-generation plasma collection system designed to enhance donor comfort and increase collection efficiency.

equipe executiva do Haemonetics

  • Mr. Christopher A. SimonCEO, President & Director
  • Mr. James C. D'Arecca CPACFO, Executive VP & Financial Officer
  • Ms. Michelle L. Basil Esq., J.D.Executive VP, General Counsel & Secretary
  • Mr. Roy GalvinExecutive VP & Chief Commercial Officer
  • Mr. Frank W. Chan Ph.D.Executive VP & COO
  • Ms. Farris Maryanne MaunsellVP, Chief Accounting Officer & Principal Accounting Officer
  • Ms. Olga GuyetteSenior Director of Investor Relations
  • Mr. Rajeev VarmaSenior Vice President of Strategy & Corporate Development
  • Ms. Laurie A. MillerSenior VP & Chief Human Resources Officer
  • Dr. Jan Hartmann M.D.Senior VP & Chief Medical Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.